ArticleJournal of experimental & clinical cancer research : CR2026
Disrupting MED8-dependent epigenetic reprogramming augments avapritinib sensitivity in PDGFRA-driven glioma.
Han Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.